Market Overview:
The global hemostatic / tissue sealants market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of surgical procedures, technological advancements in hemostatic / tissue sealants, and rising demand for minimally invasive surgeries. Based on type, the global hemostatic / tissue sealants market is segmented into hemostatic and tissue sealants. Hemostatics are used to stop bleeding during surgery while tissue sealants are used to close wounds and prevent leakage of blood or other fluids from tissues. Based on application, the global hemostatic /tissue sealant market is segmented into minimally invasive surgery (MIS), ordinary surgery, and others (including urology & gynecology surgeries). MIS accounted for the largest share of the global hemostatic/tissue sealant market in 2017 owing to its advantages over traditional open surgeries such as reduced hospital stay time, less post-operative pain & discomfort, and shorter recovery time period. Geographically, North America dominates the global hemstotic/tissue sealtant marke with a share of 36%. This can be attributedto th ehigh prevalenceof chronic diseases such as cancerand obesityin this region which leads tom issionarysurgeries being performed more often than ordinar ysurgeries .
Product Definition:
Hemostatic agents are substances that promote hemostasis, the arrest of bleeding. Hemostatic agents work by various mechanisms, including clotting factors, thrombin, fibrinogen, von Willebrand factor (vWF), and platelet aggregation. Hemostatic agents can be used in the management of both trauma and non-trauma patients. Tissue sealants are products that are applied to a wound to create a physical barrier between the wound edges and prevent or reduce fluid leakage from the wound.
Hemostatic:
Hemostatic sealants are used to stop bleeding by forming a physical barrier across the wound. They can be made from natural materials such as silk, wool and blood vessels or synthetic materials such as polyethylene glycol (PEG) and silicone. The hemostatic agent is most commonly used in combination with another material for better adhesion or alone for single-use in various medical applications including skin closure surgeries, venous leg ulcers treatment & burn cases among others.
Tissue Sealants:
Tissue sealants are synthetic or natural materials that are used to close bleeding points in the body. They have a hemostatic effect and prevent blood loss from several internal organs. Tissue sealants act as a substitute for coagulation factors and help stop bleeding by forming a physical barrier across the damaged area, which prevents further injury to cells.
The global tissue sealants and it's usage in hemostatic market was valued at USD 648 million in 2015.
Application Insights:
The others segment held the largest market share in 2017 and is anticipated to witness the fastest growth over the forecast period. This can be attributed to a rise in demand for tissue sealants from minimally invasive as well as ordinary surgeries. Minimally invasive surgeries require minimal surgical procedures, which also means lesser number of tissues that need sealing. As a result, demand for hemostatic/tissue sealants is expected to increase from ordinary surgeries over the forecast period.
Minimally invasive as well as Ordinary surgery both require proper closure of wounds after surgery using tissue sealant products so that there is no leakage of body fluids or other substances into surrounding tissues or organs post-surgery. Hence, rising number of minimally invasive and ordinary surgeries across various parts of globe are expected to drive product demand globally over next seven years.
Regional Analysis:
North America dominated the global market in 2017 owing to factors such as increasing prevalence of cardiovascular diseases, cancer, and diabetes; rising number of surgeries; and growing preference for minimally invasive surgeries. Moreover, high adoption rate of advanced technologies in this region is also expected to drive the regional demand for hemostatic/tissue sealants over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to factors such as improving healthcare infrastructure leading to increased awareness about various surgical procedures and their benefits along with government initiatives promoting medical tourism in this region. In addition, booming medical device industry coupled with favorable government policies aimed at boosting domestic production levels is further expected fuel market growth during the projected period.
Growth Factors:
- Increasing incidence of trauma and accidents, which leads to the need for hemostatic agents and tissue sealants
- Growing demand for minimally invasive surgeries, which requires the use of hemostatic agents and tissue sealants for faster healing and reduced scarring
- Rising prevalence of cancer, which leads to an increased demand for surgical procedures that require the use of hemostatic agents and tissue sealants
- Technological advancements in the field of hemostasis that lead to the development of novel products with better efficacy and fewer side effects
- increasing healthcare expenditure by governments and private players, which will lead to an increase in demand for advanced medical treatments such as those involving hemostatic agents
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemostatic / Tissue Sealants Market Research Report
By Type
Hemostatic, Tissue Sealants
By Application
Minimally Invasive Surgery, Ordinary Surgery, others
By Companies
J&J, Baxter, C R Bard, B Braun, Integra Life Sciences, Advance Medical Solution, CSL Behring, CryoLife, Zimmer Biomet, Pfizer , Medtronic, Smith & Nephew, Cohera Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Hemostatic / Tissue Sealants Market Report Segments:
The global Hemostatic / Tissue Sealants market is segmented on the basis of:
Types
Hemostatic, Tissue Sealants
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Minimally Invasive Surgery, Ordinary Surgery, others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- J&J
- Baxter
- C R Bard
- BÂ Braun
- Integra Life Sciences
- Advance Medical Solution
- CSL Behring
- CryoLife
- Zimmer Biomet
- PfizerÂ
- Medtronic
- Smith & Nephew
- Cohera Medical
Highlights of The Hemostatic / Tissue Sealants Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hemostatic
- Tissue Sealants
- By Application:
- Minimally Invasive Surgery
- Ordinary Surgery
- others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemostatic / Tissue Sealants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemostatic / Tissue Sealants are a type of medical adhesive that helps to seal wounds and stop bleeding. They can be used on both internal and external wounds, and are often used in conjunction with other medical treatments such as antibiotics or surgery. Hemostatic / Tissue Sealants can help to prevent infection, promote healing, and reduce the risk of scarring.
Some of the major players in the hemostatic / tissue sealants market are J&J, Baxter, C R Bard, B‚Â Braun, Integra Life Sciences, Advance‚Â Medical‚Â Solution, CSL Behring, CryoLife, Zimmer Biomet, Pfizer‚Â , Medtronic, Smith & Nephew, Cohera Medical.
The hemostatic / tissue sealants market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemostatic / Tissue Sealants Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemostatic / Tissue Sealants Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemostatic / Tissue Sealants Market - Supply Chain
4.5. Global Hemostatic / Tissue Sealants Market Forecast
4.5.1. Hemostatic / Tissue Sealants Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemostatic / Tissue Sealants Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemostatic / Tissue Sealants Market Absolute $ Opportunity
5. Global Hemostatic / Tissue Sealants Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemostatic / Tissue Sealants Market Size and Volume Forecast by Type
5.3.1. Hemostatic
5.3.2. Tissue Sealants
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemostatic / Tissue Sealants Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemostatic / Tissue Sealants Market Size and Volume Forecast by Application
6.3.1. Minimally Invasive Surgery
6.3.2. Ordinary Surgery
6.3.3. others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemostatic / Tissue Sealants Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemostatic / Tissue Sealants Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemostatic / Tissue Sealants Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemostatic / Tissue Sealants Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemostatic / Tissue Sealants Demand Share Forecast, 2019-2026
9. North America Hemostatic / Tissue Sealants Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemostatic / Tissue Sealants Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemostatic / Tissue Sealants Market Size and Volume Forecast by Application
9.4.1. Minimally Invasive Surgery
9.4.2. Ordinary Surgery
9.4.3. others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemostatic / Tissue Sealants Market Size and Volume Forecast by Type
9.7.1. Hemostatic
9.7.2. Tissue Sealants
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemostatic / Tissue Sealants Demand Share Forecast, 2019-2026
10. Latin America Hemostatic / Tissue Sealants Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemostatic / Tissue Sealants Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemostatic / Tissue Sealants Market Size and Volume Forecast by Application
10.4.1. Minimally Invasive Surgery
10.4.2. Ordinary Surgery
10.4.3. others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemostatic / Tissue Sealants Market Size and Volume Forecast by Type
10.7.1. Hemostatic
10.7.2. Tissue Sealants
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemostatic / Tissue Sealants Demand Share Forecast, 2019-2026
11. Europe Hemostatic / Tissue Sealants Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemostatic / Tissue Sealants Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemostatic / Tissue Sealants Market Size and Volume Forecast by Application
11.4.1. Minimally Invasive Surgery
11.4.2. Ordinary Surgery
11.4.3. others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemostatic / Tissue Sealants Market Size and Volume Forecast by Type
11.7.1. Hemostatic
11.7.2. Tissue Sealants
11.8. Basis Point Share(BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemostatic / Tissue Sealants Demand Share, 2019-2026
12. Asia Pacific Hemostatic / Tissue Sealants Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemostatic / Tissue Sealants Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemostatic / Tissue Sealants Market Size and Volume Forecast by Application
12.4.1. Minimally Invasive Surgery
12.4.2. Ordinary Surgery
12.4.3. others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemostatic / Tissue Sealants Market Size and Volume Forecast by Type
12.7.1. Hemostatic
12.7.2. Tissue Sealants
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemostatic / Tissue Sealants Demand Share, 2019-2026
13. Middle East & Africa Hemostatic / Tissue Sealants Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemostatic / Tissue Sealants Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemostatic / Tissue Sealants Market Size and Volume Forecast by Application
13.4.1. Minimally Invasive Surgery
13.4.2. Ordinary Surgery
13.4.3. others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemostatic / Tissue Sealants Market Size and Volume Forecast by Type
13.7.1. Hemostatic
13.7.2. Tissue Sealants
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemostatic / Tissue Sealants Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemostatic / Tissue Sealants Market: Market Share Analysis
14.2. Hemostatic / Tissue Sealants Distributors and Customers
14.3. Hemostatic / Tissue Sealants Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. J&J
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baxter
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. C R Bard
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. B Braun
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Integra Life Sciences
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Advance Medical Solution
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CSL Behring
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. CryoLife
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Zimmer Biomet
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pfizer
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Medtronic
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Smith & Nephew
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Cohera Medical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
